Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study (PASS).

Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW.

J Urol. 2019 Oct 25:101097JU0000000000000621. doi: 10.1097/JU.0000000000000621. [Epub ahead of print]

PMID:
31651227
2.

What Goes Up Must Come Down: Identifying Truth from Global Prostate Cancer Epidemiology.

Nyame YA, Gore JL.

Eur Urol. 2019 Oct 16. pii: S0302-2838(19)30738-9. doi: 10.1016/j.eururo.2019.09.018. [Epub ahead of print] No abstract available.

PMID:
31627967
3.

What is the Impact of Racial Disparities on Diagnosis and Receipt of Appropriate Mental Health Care Among Urology Patients?

Washington SL 3rd, Nyame YA, Moses KA.

Eur Urol Focus. 2019 Sep 18. pii: S2405-4569(19)30275-5. doi: 10.1016/j.euf.2019.08.017. [Epub ahead of print]

PMID:
31542408
4.

Editorial Comment.

Nyame YA, Wright JL.

J Urol. 2019 Nov;202(5):934-935. doi: 10.1097/01.JU.0000578532.32446.3d. Epub 2019 Oct 9. No abstract available.

PMID:
31343944
5.

Editorial Comment.

Sundi D, Nyame YA.

J Urol. 2019 Aug;202(2):254-255. doi: 10.1097/01.JU.0000559947.40119.5a. Epub 2019 Jul 8. No abstract available.

PMID:
31107157
6.

Older Age at Diagnosis and Initial Disease Volume Predict Grade Reclassification Risk on Confirmatory Biopsy in Patients Considered for Active Surveillance.

Dai C, Ganesan V, Nyame YA, Almassi N, Greene DJ, Hettel D, Magi-Galluzzi C, Gong M, Jones JS, Stephenson AJ, Berglund RK, Klein EA.

Urology. 2019 Aug;130:106-112. doi: 10.1016/j.urology.2019.02.050. Epub 2019 May 7.

PMID:
31071349
7.

EDITORIAL COMMENT.

Nyame YA.

Urology. 2019 May;127:40-41. doi: 10.1016/j.urology.2018.10.062. No abstract available.

PMID:
31003640
8.

Assessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancer.

Nyame YA, Wilkins L, Greene DJ, Ganesan V, Dai C, Almassi N, Stephenson AJ, Gong M, Berglund R, Klein EA.

Prostate Cancer Prostatic Dis. 2019 Dec;22(4):617-623. doi: 10.1038/s41391-019-0147-0. Epub 2019 Apr 17.

PMID:
30996285
9.

Does time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome?

Reichard CA, Nyame YA, Sundi D, Tosoian J, Wilkins L, Alam R, Achim MF, Wang X, Stephenson AJ, Klein EA, Ross AE, Davis JW, Chapin BF.

BJU Int. 2019 Aug;124(2):282-289. doi: 10.1111/bju.14671. Epub 2019 Feb 10.

PMID:
30653804
10.

AUTHOR REPLY.

Nyame YA, Abelson B, Khanna A, Goldman HB.

Urology. 2019 Jan;123:112-113. doi: 10.1016/j.urology.2018.06.067. No abstract available.

PMID:
30598199
11.

Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers.

Sundi D, Tosoian JJ, Nyame YA, Alam R, Achim M, Reichard CA, Li J, Wilkins L, Schwen Z, Han M, Davis JW, Klein EA, Schaeffer EM, Stephenson AJ, Ross AE, Chapin BF.

Cancer. 2019 Feb 1;125(3):391-397. doi: 10.1002/cncr.31833. Epub 2018 Nov 13.

PMID:
30423193
12.

A Contemporary Analysis of Outcomes and Modifiable Risk Factors of Ethnic Disparities in Kidney Transplantation.

Wilkins LJ, Nyame YA, Gan V, Lin S, Greene DJ, Flechner SM, Modlin CS.

J Natl Med Assoc. 2019 Apr;111(2):202-209. doi: 10.1016/j.jnma.2018.10.011. Epub 2018 Nov 6.

PMID:
30409716
13.

Perioperative Troponin is a Predictor of Both Short- and Intermediate-term Mortality Among Patients Undergoing Major Urologic Surgery.

Nyame YA, Abelson B, Khanna A, Menon V, Klein EA, Goldman HB.

Urology. 2019 Jan;123:108-113. doi: 10.1016/j.urology.2018.06.060. Epub 2018 Sep 7.

PMID:
30201299
14.

Precise Clamping of Renal Artery With Endovascular Stents During Robotic Partial Nephrectomy: Technical Hints to Optimize Outcomes.

Garisto JD, Dagenais J, Nyame Y, Sagalovich D, Bertolo R, Kaouk JH.

Urology. 2018 Aug;118:239-240. doi: 10.1016/j.urology.2018.03.023. Epub 2018 Apr 25.

PMID:
29704583
15.

Isolated Right Varicocele and Incidence of Associated Cancer.

Elmer DeWitt M, Greene DJ, Gill B, Nyame Y, Haywood S, Sabanegh E Jr.

Urology. 2018 Jul;117:82-85. doi: 10.1016/j.urology.2018.03.047. Epub 2018 Apr 9.

PMID:
29649544
16.

Spermatic Vein Thrombosis.

Murthy PB, Gill BC, Khurana S, Nyame YA, Sabanegh ES, Kaouk JH.

Urology. 2018 Sep;119:32-34. doi: 10.1016/j.urology.2018.02.024. Epub 2018 Mar 1. No abstract available.

PMID:
29501714
17.

Robot-assisted ureteral reconstruction - current status and future directions.

Babbar P, Yerram N, Sun A, Hemal S, Murthy P, Bryk D, Nandanan N, Nyame Y, Caveney M, Nelson R, Berglund R.

Urol Ann. 2018 Jan-Mar;10(1):7-14. doi: 10.4103/UA.UA_94_17. Review.

18.

Development of a Clinically Relevant Men's Health Phenotype and Correlation of Systemic and Urologic Conditions.

Shoskes DA, Vij SC, Shoskes A, Nyame Y, Gao T.

Urology. 2018 Apr;114:77-82. doi: 10.1016/j.urology.2017.12.035. Epub 2018 Jan 31.

PMID:
29360485
19.

American Urological Association Antibiotic Best Practice Statement and Ureteroscopy: Does Antibiotic Stewardship Help?

Greene DJ, Gill BC, Hinck B, Nyame YA, Almassi N, Krishnamurthi V, Noble M, Sivalingam S, Monga M.

J Endourol. 2018 Apr;32(4):283-288. doi: 10.1089/end.2017.0796. Epub 2018 Jan 3.

PMID:
29179565
20.

Associations Between Prostate Volume and Oncologic Outcomes in Men Undergoing Focal Cryoablation of the Prostate.

Elshafei A, Tay KJ, Kara O, Malkoc E, Nyame Y, Arora H, Hatem A, Patel SA, Lugnani F, Polascik TJ, Jones JS.

Clin Genitourin Cancer. 2018 Apr;16(2):e477-e482. doi: 10.1016/j.clgc.2017.10.009. Epub 2017 Oct 28.

PMID:
29174470
21.

Genomic Scores are Independent of Disease Volume in Men with Favorable Risk Prostate Cancer: Implications for Choosing Men for Active Surveillance.

Nyame YA, Grimberg DC, Greene DJ, Gupta K, Kartha GK, Berglund R, Gong M, Stephenson AJ, Magi-Galluzzi C, Klein EA.

J Urol. 2018 Feb;199(2):438-444. doi: 10.1016/j.juro.2017.09.077. Epub 2017 Sep 20.

PMID:
28941920
22.

Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable Features.

Dai C, Ganesan V, Zabell J, Nyame YA, Almassi N, Greene DJ, Hettel D, Reichard C, Haywood SC, Arora H, Zampini A, Crane A, Li J, Elshafei A, Magi-Galluzzi C, Stein RJ, Fareed K, Gong M, Jones JS, Klein EA, Stephenson AJ.

J Urol. 2018 Feb;199(2):445-452. doi: 10.1016/j.juro.2017.08.006. Epub 2017 Aug 5.

PMID:
28789947
23.

Prognostic Significance of a Negative Confirmatory Biopsy on Reclassification Among Men on Active Surveillance.

Ganesan V, Dai C, Nyame YA, Greene DJ, Almassi N, Hettel D, Zabell J, Arora H, Haywood S, Crane A, Reichard C, Zampini A, Elshafei A, Stein RJ, Fareed K, Jones JS, Gong M, Stephenson AJ, Klein EA, Berglund RK.

Urology. 2017 Sep;107:184-189. doi: 10.1016/j.urology.2017.06.014. Epub 2017 Jun 15.

PMID:
28625591
24.

Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation.

Nyame YA, Elshafei A, Greene DJ, Arora HC, Given RW, Tay KJ, Polascik TJ, Ross AE, Mouraviev VB, Lugnani F, Jones JS.

J Endourol. 2017 May;31(5):497-501. doi: 10.1089/end.2016.0715.

PMID:
28437170
25.

Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance.

Nyame YA, Almassi N, Haywood SC, Greene DJ, Ganesan V, Dai C, Zabell J, Reichard C, Arora H, Zampini A, Crane A, Hettel D, Elshafei A, Fareed K, Stein RJ, Berglund RK, Gong M, Jones JS, Klein EA, Stephenson AJ.

J Urol. 2017 Sep;198(3):591-599. doi: 10.1016/j.juro.2017.03.123. Epub 2017 Mar 24.

PMID:
28347770
26.

Ex-vivo partial nephrectomy after living donor nephrectomy: Surgical technique for expanding kidney donor pool.

Nyame YA, Babbar P, Aboumohamed AA, Mori RL, Flechner SM, Modlin CS.

Urol Ann. 2017 Jan-Mar;9(1):107-109. doi: 10.4103/0974-7796.198913.

27.

Clinical Predictors of 30-Day Emergency Department Revisits for Patients with Ureteral Stones.

Ganesan V, Loftus CJ, Hinck B, Greene DJ, Nyame YA, Sivalingam S, Monga M.

J Urol. 2016 Nov;196(5):1467-1470. doi: 10.1016/j.juro.2016.05.031. Epub 2016 May 10.

PMID:
27177427
28.

Do Renin-Angiotensin Blockers Affect Renal Function and Cardiac Outcomes in Patients Undergoing Partial Nephrectomy?

Nyame YA, Liang H, Arora HC, Gill BC, Caputo P, Ramirez D, Maurice MJ, Fareed K, Stein RJ, Haber GP, Stephenson AJ, Fergany A, Kaouk J.

J Urol. 2017 Mar;197(3 Pt 1):566-573. doi: 10.1016/j.juro.2016.10.054. Epub 2016 Oct 13.

PMID:
27746281
29.

Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?

Murphy AB, Nyame YA, Batai K, Kalu R, Khan A, Gogana P, Dixon M, Macias V, Kajdacsy-Balla A, Hollowell CM, Catalona WJ, Kittles R.

Prostate Cancer Prostatic Dis. 2017 Mar;20(1):55-60. doi: 10.1038/pcan.2016.41. Epub 2016 Oct 11.

30.

Reply to E. Roca et al.

Nyame YA, Murphy AB, Jordan G, Gogana P, Hollowell CMP, Catalona WJ, Kittles R.

J Clin Oncol. 2016 Oct 20;34(30):3710-3711. doi: 10.1200/JCO.2016.68.9299. No abstract available.

PMID:
27458284
31.

The nomogram conundrum: a demonstration of why a prostate cancer risk model in Turkish men underestimates prostate cancer risk in the USA.

Kara O, Elshafei A, Nyame YA, Akdogan B, Malkoc E, Gao T, Altan M, Citamak B, Mammadov E, Dursun F, Greene DJ, Senkul T, Ates F, Ozen H, Stephen Jones J.

Int Urol Nephrol. 2016 Oct;48(10):1623-9. doi: 10.1007/s11255-016-1328-6. Epub 2016 May 28.

PMID:
27236298
32.

External validation of a PCA-3-based nomogram for predicting prostate cancer and high-grade cancer on initial prostate biopsy.

Greene DJ, Elshafei A, Nyame YA, Kara O, Malkoc E, Gao T, Jones JS.

Prostate. 2016 Aug;76(11):1019-23. doi: 10.1002/pros.23197. Epub 2016 May 16.

PMID:
27197726
33.

Robotic-assisted Laparoscopic Bilateral Nerve Sparing and Apex Preserving Cystoprostatectomy in Young Men With Bladder Cancer.

Nyame YA, Zargar H, Ramirez D, Ganesan V, Babbar P, Villers A, Haber GP.

Urology. 2016 Aug;94:259-64. doi: 10.1016/j.urology.2016.04.026. Epub 2016 Apr 28.

PMID:
27132504
34.

Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy.

Nyame YA, Murphy AB, Bowen DK, Jordan G, Batai K, Dixon M, Hollowell CM, Kielb S, Meeks JJ, Gann PH, Macias V, Kajdacsy-Balla A, Catalona WJ, Kittles R.

J Clin Oncol. 2016 Apr 20;34(12):1345-9. doi: 10.1200/JCO.2015.65.1463. Epub 2016 Feb 22.

35.

Robotic Anterior Pelvic Exenteration for Bladder Cancer in Patient With Previous Kidney-Pancreas Transplantation.

Nyame YA, Nandanan N, Greene DJ, Krishnamurthi V, Haber GP.

Urology. 2016 Apr;90:200-3. doi: 10.1016/j.urology.2015.12.033. Epub 2015 Dec 29.

PMID:
26743393
36.

More Favorable Pathological Outcomes in Men with Low Risk Prostate Cancer Diagnosed on Repeat versus Initial Transrectal Ultrasound Guided Prostate Biopsy.

ElShafei A, Nyame Y, Kara O, Badawy A, Amujiogu I, Fareed K, Klein E, Jones JS.

J Urol. 2016 Jun;195(6):1767-72. doi: 10.1016/j.juro.2015.12.079. Epub 2015 Dec 24.

PMID:
26724397
37.

Medical Expulsive Therapy is Underused for the Management of Renal Colic in the Emergency Setting.

Loftus C, Nyame Y, Hinck B, Greene D, Chaparala H, Alazem K, Monga M.

J Urol. 2016 Apr;195(4 Pt 1):987-91. doi: 10.1016/j.juro.2015.11.026. Epub 2015 Nov 17.

PMID:
26598425
38.

Re: Long-term Follow-up of a Large Active Surveillance Cohort of Patients with Prostate Cancer.

Nyame YA, Stephenson AJ, Klein E.

Eur Urol. 2015 Nov;68(5):906-7. doi: 10.1016/j.eururo.2015.07.064. No abstract available.

PMID:
26460873
39.

Comparative Cost-Effectiveness Analysis of Modified 1-Layer versus Formal 2-Layer Vasovasostomy Technique.

Nyame YA, Babbar P, Almassi N, Polackwich AS, Sabanegh E.

J Urol. 2016 Feb;195(2):434-8. doi: 10.1016/j.juro.2015.08.102. Epub 2015 Sep 24.

PMID:
26388500
40.

Kidney Stone Models for In Vitro Lithotripsy Research: A Comprehensive Review.

Nyame YA, De S, Sarkissian C, Brown R, Kartha G, Babbar P, Monga M.

J Endourol. 2015 Oct;29(10):1106-9. doi: 10.1089/end.2014.0850. Epub 2015 Jun 30. No abstract available.

PMID:
25924100
41.

Are HIV-infected men vulnerable to prostate cancer treatment disparities?

Murphy AB, Bhatia R, Martin IK, Klein DA, Hollowell CMP, Nyame Y, Dielubanza E, Achenbach C, Kittles RA.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2009-2018. doi: 10.1158/1055-9965.EPI-14-0614. Epub 2014 Jul 25.

42.

Vitamin D deficiency predicts prostate biopsy outcomes.

Murphy AB, Nyame Y, Martin IK, Catalona WJ, Hollowell CM, Nadler RB, Kozlowski JM, Perry KT, Kajdacsy-Balla A, Kittles R.

Clin Cancer Res. 2014 May 1;20(9):2289-99. doi: 10.1158/1078-0432.CCR-13-3085.

43.

Smoking and prostate cancer in a multi-ethnic cohort.

Murphy AB, Akereyeni F, Nyame YA, Guy MC, Martin IK, Hollowell CM, Walker K, Kittles RA, Ahaghotu C.

Prostate. 2013 Oct;73(14):1518-28. doi: 10.1002/pros.22699. Epub 2013 Jul 3.

44.

Predictors of serum vitamin D levels in African American and European American men in Chicago.

Murphy AB, Kelley B, Nyame YA, Martin IK, Smith DJ, Castaneda L, Zagaja GJ, Hollowell CM, Kittles RA.

Am J Mens Health. 2012 Sep;6(5):420-6. doi: 10.1177/1557988312437240. Epub 2012 Mar 7.

45.

Recurrent headaches in children: an epidemiological survey of two middle schools in inner city Chicago.

Nyame YA, Ambrosy AP, Saps M, Adams PN, Dhroove GN, Suresh S.

Pain Pract. 2010 May-Jun;10(3):214-21. doi: 10.1111/j.1533-2500.2009.00338.x. Epub 2010 Jan 8.

PMID:
20070550
46.

Regulating self-assembly of spherical oligomers.

Johnson JM, Tang J, Nyame Y, Willits D, Young MJ, Zlotnick A.

Nano Lett. 2005 Apr;5(4):765-70.

PMID:
15826125

Supplemental Content

Support Center